« Previous
Next »
Titles
- Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment1
- Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: developing drugs for treatment1
- Human gene therapy for hemophilia1
- Human gene therapy for rare diseases1
- Human gene therapy for retinal disorders1